My watch list  


Systematic (IUPAC) name
CAS number 83480-29-9
ATC code A10BF03
PubChem 444020
Chemical data
Formula C10H21NO7 
Mol. mass 267.28 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Voglibose (INN and USAN) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.

glenmark is also producing voglibose under brand name vocarb.

Diabetes is chronic metabolic disorder characterised by hyperglycemia which is due to relative or absolute deficiency of insulin or insulin resistance.

PPHG is termed as Post Prandial Hyperglycemia which is primarily due to first phase insulin secretion. Alpha glucosidase inhibitor is one agent which delays the glucose absorption at the intestine level and thereby prevents sudden surge of glucose post meal.

There are three molecules which belong to this class namely, Acarbose, Miglitol and Voglibose. Voglibose is the latest molecule in this class. Voglibose scores over both Acarbose and MIglitol in terms of potenty and side effect profile.

There are several trials supporting the use of Voglibose in the management of PPHG. Also, it has been established that it is PPHG not FPG which is marker of cardiovascular disorders associeted with diabetes. So, controlling PPHG is imperative and Voglibose is indicated for the management of PPHG.

Sun Pharmaceuticals launched Voglibose 0.2 / 0.3 mg under the brand name VOLIBO.

For any further enquiry, pls write to

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Voglibose". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE